- Genfit S.A. press release (OTCPK:GNFTF): 1H GAAP EPS of -€0.20.
- Revenue of €35.67M (-41.7% Y/Y).
- Cash and cash equivalents totaled €107.5 million as of June 30, 2025, excluding the €26.5 million milestone invoiced in May 2025 (received in July 2025) upon pricing and reimbursement approval of Iqirvo® (elafibranor) in
